Methods and compositions for diagnosing conditions

A product, tissue technology, applied in the field of diagnosis of pathological conditions and composition, which can solve the problems of increasing treatment costs, economic and physical harm

Active Publication Date: 2013-04-10
VERACYTE INC
View PDF33 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Continued escalation in treatment costs and complications due to the need for lifelong drug therapy to replace lost thyroid function can lead to further financial and physical harm

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for diagnosing conditions
  • Methods and compositions for diagnosing conditions
  • Methods and compositions for diagnosing conditions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0291] Example 1: Classification panels from analysis of clinical thyroid samples

[0292] Prospective clinical thyroid FNA samples (n=248) and postoperative thyroid tissue (n=220) were examined with the Affymetrix Human Exon 1.0ST microarray with the aim of identifying genes with significantly different mRNA expression between benign and malignant samples.

[0293] Intensity data from approximately 6.5 million probes were extracted, normalized and aggregated using Affymetrix software. A core probe set of approximately 280,000 was subsequently used in feature selection and classification. The models used include LIMMA (for feature selection) and SVM (for classification) (Smyth 2004). A combination of LIMMA and algorithms were used in several separate analyses, to identify the top genes used in each taxonomic group.

[0294] While the annotation and mapping of genes to transcript cluster identifiers (TCIDs) is continuously evolving, the nucleotide sequences of the probes and ...

Embodiment 2

[0300] Example 2: Molecular profiling of thyroid nodules

[0301] Subject notes a lump on their thyroid. The individual consults his family physician. The family physician decided to obtain a sample from the mass and perform molecular profiling on it. The physician uses the kit to obtain a sample by fine needle aspiration, performs an adequacy test, stores the sample in a liquid-based cytology solution, and sends it to the molecular profiling business. Optionally, the doctor may have cytology done by another party or a laboratory. If cytology results in an inconclusive diagnosis, the remainder of the sample is sent to the molecular profiling business or a third party. Molecular profiling companies split the samples, some for cytological analysis, and the remainder for mRNA extraction from the samples, analyze the quality and suitability of the extracted mRNA samples, and analyze the expression of a subset of the genes listed in Figure 4 Levels and alternative exon usage. ...

Embodiment 3

[0303] Example 3: Identification of Hurthle cell adenoma and Hurthle cell carcinoma in thyroid tissue

[0304] Postoperative thyroid tissue samples and clinical thyroid FNA biopsy samples were examined using the Affymetrix Human Exon 1.0ST microarray with the aim of identifying biomarkers whose mRNA expression was significantly different between benign and malignant samples. These biomarkers were then used to train a molecular classifier using the same cohort of postoperative tissue samples. Information learned during training of the algorithm using tissue samples, including but not limited to biomarker selection for each thyroid subtype, is combined with the next step of training the algorithm using clinical FNA samples such that biomarkers in FNA can be maintained The high-dimensional nature of molecular expression and use it to train optimized or next-generation molecular classifiers. By combining information learned from tissue and clinical FNA, we demonstrate that the mo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The present invention relates to compositions, kits, and methods for molecular profiling for diagnosing disease conditions. In particular, the present invention provides molecular profiles associated with thyroid cancer and other cancers, methods of relating molecular profiles to a diagnosis, and related compositions.

Description

[0001] cross reference [0002] This application claims priority to the following U.S. Provisional Patent Applications: U.S. Provisional Application No. 61 / 333,717, filed May 11, 2010; and U.S. Provisional Application No. 61 / 389,810, filed October 5, 2010; each of which is incorporated by reference All incorporated herein. Background technique [0003] There is a need in the art for more accurate methods of classifying, characterizing and diagnosing diseases or conditions. For example, cancer is one of the leading causes of death worldwide; however, the first step of simply identifying an accurate diagnosis is often a frustrating and time-consuming experience for many patients. This is true for many cancers, including thyroid cancer. This is also especially true for relatively rare diseases such as Hurthle cell adenoma and Hurthle cell carcinoma, which account for approximately 5% of thyroid tumors. [0004] An inaccurate diagnosis of cancer can lead to unnecessary follow-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/48G16B25/10G16B40/20G16B40/30
CPCC12Q1/6886C12Q2600/158G16B40/20G16B25/10G16B40/30C12Q1/6809C12Q1/6883G01N33/57407C12Q2600/106G16B25/00G16B40/00Y02A90/10C12Q2537/149
Inventor G·C·肯尼迪D·I·丘多瓦J·I·威尔德詹姆斯·G·维奇邦妮·H·安德森
Owner VERACYTE INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products